These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 15203917)

  • 1. Induction of partial protection in mice after oral administration of Lactococcus lactis producing Brucella abortus L7/L12 antigen.
    Pontes DS; Dorella FA; Ribeiro LA; Miyoshi A; Le Loir Y; Gruss A; Oliveira SC; Langella P; Azevedo V
    J Drug Target; 2003; 11(8-10):489-93. PubMed ID: 15203917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production and targeting of the Brucella abortus antigen L7/L12 in Lactococcus lactis: a first step towards food-grade live vaccines against brucellosis.
    Ribeiro LA; Azevedo V; Le Loir Y; Oliveira SC; Dieye Y; Piard JC; Gruss A; Langella P
    Appl Environ Microbiol; 2002 Feb; 68(2):910-6. PubMed ID: 11823235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influenza viral vectors expressing the Brucella OMP16 or L7/L12 proteins as vaccines against B. abortus infection.
    Tabynov K; Sansyzbay A; Kydyrbayev Z; Yespembetov B; Ryskeldinova S; Zinina N; Assanzhanova N; Sultankulova K; Sandybayev N; Khairullin B; Kuznetsova I; Ferko B; Egorov A
    Virol J; 2014 Apr; 11():69. PubMed ID: 24716528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Live vaccine consisting of attenuated Salmonella secreting and delivering Brucella ribosomal protein L7/L12 induces humoral and cellular immune responses and protects mice against virulent Brucella abortus 544 challenge.
    Senevirathne A; Hewawaduge C; Lee JH
    Vet Res; 2020 Jan; 51(1):6. PubMed ID: 31973749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Over-expression of homologous antigens in a leucine auxotroph of Brucella abortus strain RB51 protects mice against a virulent B. suis challenge.
    Rajasekaran P; Surendran N; Seleem MN; Sriranganathan N; Schurig GG; Boyle SM
    Vaccine; 2011 Apr; 29(17):3106-10. PubMed ID: 21376799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Escheriosome-mediated delivery of recombinant ribosomal L7/L12 protein confers protection against murine brucellosis.
    Mallick AI; Singha H; Khan S; Anwar T; Ansari MA; Khalid R; Chaudhuri P; Owais M
    Vaccine; 2007 Nov; 25(46):7873-84. PubMed ID: 17931756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved immunogenicity and protective efficacy of a divalent DNA vaccine encoding Brucella L7/L12-truncated Omp31 fusion protein by a DNA priming and protein boosting regimen.
    Golshani M; Rafati S; Siadat SD; Nejati-Moheimani M; Shahcheraghi F; Arsang A; Bouzari S
    Mol Immunol; 2015 Aug; 66(2):384-91. PubMed ID: 25968974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleic acid vaccination of Brucella abortus ribosomal L7/L12 gene elicits immune response.
    Kurar E; Splitter GA
    Vaccine; 1997 Dec; 15(17-18):1851-7. PubMed ID: 9413093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection of BALB/C mice against Brucella abortus 544 challenge by vaccination with combination of recombinant human serum albumin-l7/l12 (Brucella abortus ribosomal protein) and lipopolysaccharide.
    Pakzad I; Rezaee A; Rasaee MJ; Hossieni AZ; Tabbaraee B; Kazemnejad A
    Roum Arch Microbiol Immunol; 2010; 69(1):5-12. PubMed ID: 21053778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PLGA (85:15) nanoparticle based delivery of rL7/L12 ribosomal protein in mice protects against Brucella abortus 544 infection: A promising alternate to traditional adjuvants.
    Singh D; Somani VK; Aggarwal S; Bhatnagar R
    Mol Immunol; 2015 Dec; 68(2 Pt A):272-9. PubMed ID: 26442664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogencity of HSA-L7/L12 (Brucella abortus ribosomal protein) in an animal model.
    Pakzad I; Rezaee A; Rasaee MJ; Tabbaraee B; Delpisheh A
    Iran J Immunol; 2009 Mar; 6(1):12-21. PubMed ID: 19293473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposomised recombinant ribosomal L7/L12 protein protects BALB/c mice against Brucella abortus 544 infection.
    Mallick AI; Singha H; Chaudhuri P; Nadeem A; Khan SA; Dar KA; Owais M
    Vaccine; 2007 May; 25(18):3692-704. PubMed ID: 17296251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective and therapeutic efficacy study of divalent fusion protein rL7/L12-Omp25 against B. abortus 544 in presence of IFNγ.
    Paul S; Peddayelachagiri BV; Nagaraj S; Konduru B; Batra HV
    Appl Microbiol Biotechnol; 2018 Oct; 102(20):8895-8907. PubMed ID: 30136204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective immunity elicited by a divalent DNA vaccine encoding both the L7/L12 and Omp16 genes of Brucella abortus in BALB/c mice.
    Luo D; Ni B; Li P; Shi W; Zhang S; Han Y; Mao L; He Y; Wu Y; Wang X
    Infect Immun; 2006 May; 74(5):2734-41. PubMed ID: 16622210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination with recombinant L7/L12-truncated Omp31 protein induces protection against Brucella infection in BALB/c mice.
    Golshani M; Rafati S; Dashti A; Gholami E; Siadat SD; Oloomi M; Jafari A; Bouzari S
    Mol Immunol; 2015 Jun; 65(2):287-92. PubMed ID: 25723468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral immunization of mice with recombinant Lactococcus lactis expressing Cu,Zn superoxide dismutase of Brucella abortus triggers protective immunity.
    Sáez D; Fernández P; Rivera A; Andrews E; Oñate A
    Vaccine; 2012 Feb; 30(7):1283-90. PubMed ID: 22222868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune responses of mice to vaccinia virus recombinants expressing either Listeria monocytogenes partial listeriolysin or Brucella abortus ribosomal L7/L12 protein.
    Baloglu S; Boyle SM; Vemulapalli R; Sriranganathan N; Schurig GG; Toth TE
    Vet Microbiol; 2005 Aug; 109(1-2):11-7. PubMed ID: 15941627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection of mice from Brucella infection by immunization with attenuated Salmonella enterica serovar typhimurium expressing A L7/L12 and BLS fusion antigen of Brucella.
    Zhao Z; Li M; Luo D; Xing L; Wu S; Duan Y; Yang P; Wang X
    Vaccine; 2009 Aug; 27(38):5214-9. PubMed ID: 19596411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant L7/L12 protein entrapping PLGA (poly lactide-co-glycolide) micro particles protect BALB/c mice against the virulent B. abortus 544 infection.
    Singh D; Goel D; Bhatnagar R
    Vaccine; 2015 Jun; 33(24):2786-92. PubMed ID: 25930114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A combined subunit vaccine comprising BP26, Omp25 and L7/L12 against brucellosis.
    Gupta S; Singh D; Gupta M; Bhatnagar R
    Pathog Dis; 2019 Nov; 77(8):. PubMed ID: 31971564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.